Abstract:We are often confronted with a simple question, "which gene editing technique is the best?"; the simple answer is "there isn't one". In 2021, a year after prime editing first made its mark, we evaluated the landscape of this potentially transformative advance in genome engineering towards getting treatments to the clinic [1]. Nearly 20% of the papers we cited were still in pre-print at the time which serves to indicate how early-stage the knowledge base was at that time. Now, three years later, we take a look at the landscape and ask what has been learnt to ensure this tech is broadly accessible, highlighting some key advances, especially those that push this towards the clinic. A big part of the appeal of prime editing is its ability to precisely edit DNA without double stranded breaks, and to install any of the 12 possible single-nucleotide conversion events as well as small insertions and/or deletions, or essentially any combination thereof. Over the last few decades, other transformative and Nobel prize-winning technologies that rely on Watson-Crick base-pairing such as PCR, site-directed mutagenesis, RNA interference, and one might say, "classic" CRISPR, were swiftly adopted across labs around the world because of the speed with which mechanistic rules governing their efficiency were determined. Whilst this perspective focuses on the context of gene therapy applications of prime editing, we also further look at the recent studies which have increased our understanding of the mechanism of PEs and simultaneously improved the efficiency and diversity of the PE toolbox.

One Prime for All Editing.

Prime editing: Its systematic optimization and current applications in disease treatment and agricultural breeding

Prime editing for precise and highly versatile genome manipulation

Search-and-replace genome editing without double-strand breaks or donor DNA

Prime editing: therapeutic advances and mechanistic insights

A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

[Advances in base editing systems]

Prime Editing in Plants: Prospects and Challenges

A design optimized prime editor with expanded scope and capability in plants

Current advancement in the application of prime editing

The Development, Optimization and Future of Prime Editing

Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary Diseases

Development of a Versatile Nuclease Prime Editor with Upgraded Precision

Efficient Genome Editing with Chimeric Oligonucleotide-Directed Editing

Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression

The Development and Application of a Base Editor in Biomedicine

CRISPR-Cas9 DNA Base-Editing and Prime-Editing

Prime editing for functional repair in patient-derived disease models

Powerful Microbial Base-Editing Toolbox: From Optimization Strategies to Versatile Applications

Prime Editing for Human Gene Therapy: Where Are We Now?